Merck & Co. Inc. has outlined its global plans following the completion of Merck's merger with Schering-Plough Corporation.

"With our merger now complete, we are ready to deliver on the promise of a new Merck built on a foundation of scientific innovation and dedication to the well-being of patients around the world," said Richard T. Clark, chairman, president and chief executive officer of Merck. "On 'Day One' for the new Merck, we are stronger and better equipped to make a difference in the lives of people globally through our broadened, diversified portfolio of innovative medicines and vaccines, and products for consumer and animal health."

Merck is a global health care leader with a diversified portfolio of prescription medicines, vaccines, and animal and consumer health products.

Merck now has approximately 106,000 employees and operates in more than 140 countries around the world, including emerging markets. The company expects to generate more than 50% of its revenue outside the United States